Welcome to LookChem.com Sign In|Join Free

CAS

  • or
N,N'-Dicyclohexylurea, also known as U822500, is a white crystalline powder that is a substituted urea compound. It has demonstrated potent inhibitory effects on juvenile hormone epoxide hydrolase (JHEH) in the tobacco hornworm, Manduca sexta, and is related to the chemotherapeutic drug Lomustine USP.

2387-23-7 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 2387-23-7 Structure
  • Basic information

    1. Product Name: N,N'-DICYCLOHEXYLUREA
    2. Synonyms: AURORA KA-3582;1,3-DICYCLOHEXYLUREA;n,n’-dicyclohexyl-ure;N,N'-DICYCLOHEXYLUREA;N,N,-Dicyclohexylurea98.%;Dicyclohexylcarbodiamide;N,N'-Carbonylbis(cyclohexanamine);NSC 17013
    3. CAS NO:2387-23-7
    4. Molecular Formula: C13H24N2O
    5. Molecular Weight: 224.34
    6. EINECS: 219-213-7
    7. Product Categories: Carbonyl Compounds;Organic Building Blocks;Ureas;Finasteride;NULL
    8. Mol File: 2387-23-7.mol
  • Chemical Properties

    1. Melting Point: 232-233 °C(lit.)
    2. Boiling Point: 408℃
    3. Flash Point: 158℃
    4. Appearance: Clear/Liquid
    5. Density: 1.02
    6. Refractive Index: 1.4832 (estimate)
    7. Storage Temp.: Store below +30°C.
    8. Solubility: DMSO (Slightly, Heated), Methanol (Slightly)
    9. PKA: 13.89±0.20(Predicted)
    10. CAS DataBase Reference: N,N'-DICYCLOHEXYLUREA(CAS DataBase Reference)
    11. NIST Chemistry Reference: N,N'-DICYCLOHEXYLUREA(2387-23-7)
    12. EPA Substance Registry System: N,N'-DICYCLOHEXYLUREA(2387-23-7)
  • Safety Data

    1. Hazard Codes: Xn,N
    2. Statements: 22-51/53
    3. Safety Statements: 61
    4. WGK Germany: 3
    5. RTECS:
    6. TSCA: Yes
    7. HazardClass: N/A
    8. PackingGroup: N/A
    9. Hazardous Substances Data: 2387-23-7(Hazardous Substances Data)

2387-23-7 Usage

Uses

Used in Pharmaceutical Industry:
N,N'-Dicyclohexylurea is used as a research compound for its inhibitory effects on juvenile hormone epoxide hydrolase (JHEH), which can be beneficial in the development of novel treatments for various conditions, particularly those related to insect development and reproduction.
Used in Chemical Research:
As a substituted urea compound, N,N'-Dicyclohexylurea can be utilized in chemical research to study its properties, interactions, and potential applications in the synthesis of other compounds or materials.
Used in Insect Control:
N,N'-Dicyclohexylurea's potent inhibition of JHEH in the tobacco hornworm suggests its potential use in the development of insect control strategies, particularly for pests that are difficult to manage using conventional methods.
Used in Drug Development:
Due to its relationship with the chemotherapeutic drug Lomustine USP, N,N'-Dicyclohexylurea may be used in drug development to explore its potential as a therapeutic agent or to understand its mechanisms of action in the context of cancer treatment.

Preparation

An excess of dry ice (200 g) was added gradually to a solution of dicyclohexylcarbodiimide (2.06 g, 0.01 mol), cyclohexylamine (1.98 g, 0.02 mol), and triethylamine (2.2 g, 0.02 mol) in THF at 75 ℃ over a period of 8 h. After stirring for 8 h, the reaction mixture was concentrated under reduced pressure and the resultant precipitate was collected. Fractional recrystallization of the precipitate from acetone/methanol gave N,N'-dicyclohexylurea; yield 2.2 g (98% based on dicyclohexylcarbodiimide and cyclohexylamine).

Synthesis Reference(s)

The Journal of Organic Chemistry, 61, p. 4175, 1996 DOI: 10.1021/jo9522825

Check Digit Verification of cas no

The CAS Registry Mumber 2387-23-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,3,8 and 7 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 2387-23:
(6*2)+(5*3)+(4*8)+(3*7)+(2*2)+(1*3)=87
87 % 10 = 7
So 2387-23-7 is a valid CAS Registry Number.

2387-23-7 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (D0441)  1,3-Dicyclohexylurea  >98.0%(GC)(T)

  • 2387-23-7

  • 25g

  • 325.00CNY

  • Detail
  • TCI America

  • (D0441)  1,3-Dicyclohexylurea  >98.0%(GC)(T)

  • 2387-23-7

  • 100g

  • 740.00CNY

  • Detail
  • TCI America

  • (D0441)  1,3-Dicyclohexylurea  >98.0%(GC)(T)

  • 2387-23-7

  • 500g

  • 2,290.00CNY

  • Detail
  • Alfa Aesar

  • (B20805)  N,N'-Dicyclohexylurea, 98%   

  • 2387-23-7

  • 25g

  • 394.0CNY

  • Detail
  • Alfa Aesar

  • (B20805)  N,N'-Dicyclohexylurea, 98%   

  • 2387-23-7

  • 100g

  • 764.0CNY

  • Detail
  • Alfa Aesar

  • (B20805)  N,N'-Dicyclohexylurea, 98%   

  • 2387-23-7

  • 500g

  • 3466.0CNY

  • Detail
  • USP

  • (1369442)  LomustineRelatedCompoundC  United States Pharmacopeia (USP) Reference Standard

  • 2387-23-7

  • 1369442-25MG

  • 13,501.80CNY

  • Detail
  • Aldrich

  • (D80800)  N,N′-Dicyclohexylurea  98%

  • 2387-23-7

  • D80800-25G

  • 452.79CNY

  • Detail

2387-23-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 1,3-dicyclohexylurea

1.2 Other means of identification

Product number -
Other names F0902-7614

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:2387-23-7 SDS

2387-23-7Synthetic route

1-hydroxy-pyrrolidine-2,5-dione
6066-82-6

1-hydroxy-pyrrolidine-2,5-dione

(S)-2-((tert-butoxycarbonyl)amino)-3-(3-iodo-4-methoxyphenyl)propanoic acid
622336-82-7

(S)-2-((tert-butoxycarbonyl)amino)-3-(3-iodo-4-methoxyphenyl)propanoic acid

A

C19H23IN2O7
911675-87-1

C19H23IN2O7

B

1,3-Dicyclohexylurea
2387-23-7

1,3-Dicyclohexylurea

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide In 1,2-dimethoxyethaneA 100%
B n/a
cis-Octadecenoic acid
112-80-1

cis-Octadecenoic acid

N3,N6-di(tert-butoxycarbonyl)-3,6-diazaoctane-1,8-diol
167407-91-2

N3,N6-di(tert-butoxycarbonyl)-3,6-diazaoctane-1,8-diol

dicyclohexyl-carbodiimide
538-75-0

dicyclohexyl-carbodiimide

A

N,N'-di-tert-butylcarbonyl-N,N'-bis(2-hydroxyethyl)ethylenediamine dioleate
167951-93-1

N,N'-di-tert-butylcarbonyl-N,N'-bis(2-hydroxyethyl)ethylenediamine dioleate

B

1,3-Dicyclohexylurea
2387-23-7

1,3-Dicyclohexylurea

Conditions
ConditionsYield
dmap In n-heptane at 20 - 40℃; Product distribution / selectivity;A n/a
B 99.6%
carbon monoxide
201230-82-2

carbon monoxide

cyclohexylamine
108-91-8

cyclohexylamine

1,3-Dicyclohexylurea
2387-23-7

1,3-Dicyclohexylurea

Conditions
ConditionsYield
Stage #1: carbon monoxide; cyclohexylamine With selenium at 20℃; under 750.075 Torr; for 2h; neat (no solvent);
Stage #2: With oxygen at 20℃; under 750.075 Torr; for 1h; neat (no solvent);
99%
With palladium; oxygen; potassium iodide In 1,4-dioxane at 130℃; under 30003 Torr; for 24h; Autoclave; Green chemistry;99%
With oxygen In tetrahydrofuran at 90℃; under 6000.6 Torr; for 72h; Catalytic behavior; Reagent/catalyst; Autoclave; Schlenk technique; Inert atmosphere;96%
Cyclohexyl isocyanate
3173-53-3

Cyclohexyl isocyanate

1,3-Dicyclohexylurea
2387-23-7

1,3-Dicyclohexylurea

Conditions
ConditionsYield
With [Pr(SPh)3(THF)3] In tetrahydrofuran at 60℃; for 12h; Inert atmosphere;99%
With Trimethylsilanol In acetonitrile at 20℃; Green chemistry;92%
With Ta(η5-C5Me5)(η3-1-phenylallyl)2 In toluene for 12h; Ambient temperature;89%
carbon dioxide
124-38-9

carbon dioxide

cyclohexylamine
108-91-8

cyclohexylamine

1,3-Dicyclohexylurea
2387-23-7

1,3-Dicyclohexylurea

Conditions
ConditionsYield
Stage #1: cyclohexylamine With titanium tetrachloride In dichloromethane at 0℃; for 0.5h; Inert atmosphere;
Stage #2: With pyridine In dichloromethane for 0.5h; Inert atmosphere;
Stage #3: carbon dioxide Further stages;
99%
With cesium hydroxide; 1-butyl-3-methylimidazolium chloride at 170℃; under 45600 Torr; for 4h;98%
Stage #1: cyclohexylamine With tetrachloromethane; triphenylphosphine In dichloromethane for 24h; Heating;
Stage #2: With triethylamine at 20℃; for 2h;
Stage #3: carbon dioxide; cyclohexylamine at 20℃; for 24h; Further stages.;
96%
chloroform
67-66-3

chloroform

cyclohexylamine
108-91-8

cyclohexylamine

1,3-Dicyclohexylurea
2387-23-7

1,3-Dicyclohexylurea

Conditions
ConditionsYield
With oxygen; sodium hydrogencarbonate; triethylamine In water for 1h; Irradiation;99%
With oxygen; sodium hydroxide In water at 20℃; for 3h; Reagent/catalyst; Irradiation;62%
tetradecylthioacetic Acid
2921-20-2

tetradecylthioacetic Acid

methyl 2,3-diaminopropanoate dihydrochloride
6059-44-5, 106973-48-2, 147857-43-0

methyl 2,3-diaminopropanoate dihydrochloride

dicyclohexyl-carbodiimide
538-75-0

dicyclohexyl-carbodiimide

A

methyl 2,3-di{[(tetradecylthio)acetyl]amino}propanoate

methyl 2,3-di{[(tetradecylthio)acetyl]amino}propanoate

B

1,3-Dicyclohexylurea
2387-23-7

1,3-Dicyclohexylurea

Conditions
ConditionsYield
With benzotriazol-1-ol; triethylamine In dichloromethane at 0 - 20℃; for 49h;A 96%
B n/a
N-cyclohexyl-2-phenylimidazo[1,2-a]pyridin-3-amine

N-cyclohexyl-2-phenylimidazo[1,2-a]pyridin-3-amine

A

N-(pyrid-2-yl)benzamide
4589-12-2

N-(pyrid-2-yl)benzamide

B

cyclohexylamine
108-91-8

cyclohexylamine

C

1,3-Dicyclohexylurea
2387-23-7

1,3-Dicyclohexylurea

Conditions
ConditionsYield
With potassium tert-butylate; copper diacetate In m-xylene for 8h; Reagent/catalyst; Solvent; Schlenk technique; Heating; chemoselective reaction;A 96%
B n/a
C n/a
L-tyrosine methyl ester HCl
3417-91-2

L-tyrosine methyl ester HCl

dicyclohexyl-carbodiimide
538-75-0

dicyclohexyl-carbodiimide

para-chlorobenzoic acid
74-11-3

para-chlorobenzoic acid

A

C17H16ClNO4
254899-76-8

C17H16ClNO4

B

1,3-Dicyclohexylurea
2387-23-7

1,3-Dicyclohexylurea

Conditions
ConditionsYield
dmap In dichloromethane at 20℃; Inert atmosphere;A 95.3%
B n/a
4-nitro-phenol
100-02-7

4-nitro-phenol

4-[(2R,3S,5R)-5-(thymin-1-yl)-2-(trityloxymethyl)tetrahydrofuran-3-yloxy]-4-oxobutanoic acid

4-[(2R,3S,5R)-5-(thymin-1-yl)-2-(trityloxymethyl)tetrahydrofuran-3-yloxy]-4-oxobutanoic acid

A

1,3-Dicyclohexylurea
2387-23-7

1,3-Dicyclohexylurea

B

5'-O-tritylthymidine-3'-O-succinyl-(4-nitro)phenylester

5'-O-tritylthymidine-3'-O-succinyl-(4-nitro)phenylester

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide In 1,4-dioxane; pyridine for 12h; Ambient temperature;A n/a
B 95%
Boc-Arg(NO2)-OH
2188-18-3

Boc-Arg(NO2)-OH

methyl L-isoleucinate hydrochloride
18598-74-8

methyl L-isoleucinate hydrochloride

A

1,3-Dicyclohexylurea
2387-23-7

1,3-Dicyclohexylurea

B

(tert-butoxycarbonyl)-NG-nitroarginylisoleucyl methyl ester
102342-09-6

(tert-butoxycarbonyl)-NG-nitroarginylisoleucyl methyl ester

Conditions
ConditionsYield
With benzotriazol-1-ol; triethylamine; dicyclohexyl-carbodiimide In N,N-dimethyl-formamide 1.) ice bath, 1 h, 2.) 23 deg C, 15 h;A n/a
B 95%
bis-(p-nitrophenyl) carbonate
5070-13-3

bis-(p-nitrophenyl) carbonate

cyclohexylamine
108-91-8

cyclohexylamine

1,3-Dicyclohexylurea
2387-23-7

1,3-Dicyclohexylurea

Conditions
ConditionsYield
In dichloromethane for 4h; Ambient temperature;95%
dicyclohexyl-carbodiimide
538-75-0

dicyclohexyl-carbodiimide

1,3-Dicyclohexylurea
2387-23-7

1,3-Dicyclohexylurea

Conditions
ConditionsYield
With acetic acid; N-hydroxybenzenecarboximidamide In chloroform for 4h; Heating;95%
With tert-butyloxycarbonyl-methionyl-leucyl-phenylalanine; benzotriazol-1-ol; triethylamine In N,N-dimethyl-formamide at 0℃; for 3h;
With 1,3:2,4-di-O-methylene-L-arabinitol In pyridine; dimethyl sulfoxide at 20 - 25℃; for 2h;
cyclohexylamine
108-91-8

cyclohexylamine

5-nitro-1-indazolecarboxylic acid cyclohexylamide
401638-49-1

5-nitro-1-indazolecarboxylic acid cyclohexylamide

1,3-Dicyclohexylurea
2387-23-7

1,3-Dicyclohexylurea

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 155℃; for 6h;95%
1-hydroxy-pyrrolidine-2,5-dione
6066-82-6

1-hydroxy-pyrrolidine-2,5-dione

4-hydroxyphenylacetate
156-38-7

4-hydroxyphenylacetate

dicyclohexyl-carbodiimide
538-75-0

dicyclohexyl-carbodiimide

A

4-hydroxyphenylacetic acid N-hydroxysuccinimide ester
73158-83-5

4-hydroxyphenylacetic acid N-hydroxysuccinimide ester

B

1,3-Dicyclohexylurea
2387-23-7

1,3-Dicyclohexylurea

Conditions
ConditionsYield
In ethyl acetate at 0 - 4℃; for 22h;A 94.6%
B n/a
cyclohexylamine
108-91-8

cyclohexylamine

1-indazolecarboxylic acid cyclohehylamide

1-indazolecarboxylic acid cyclohehylamide

1,3-Dicyclohexylurea
2387-23-7

1,3-Dicyclohexylurea

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 155℃; for 8h;94%
cyclohexane-1,3-dicarboxylic acid
3971-31-1

cyclohexane-1,3-dicarboxylic acid

dicyclohexyl-carbodiimide
538-75-0

dicyclohexyl-carbodiimide

A

1,3-Dicyclohexylurea
2387-23-7

1,3-Dicyclohexylurea

B

3-oxabicyclo[3.3.1]nonane-2,4-dione
4355-31-1

3-oxabicyclo[3.3.1]nonane-2,4-dione

Conditions
ConditionsYield
In dichloromethane at 20℃; for 4h;A n/a
B 94%
1,3-Dicyclohexylurea
2387-23-7

1,3-Dicyclohexylurea

dicyclohexyl-carbodiimide
538-75-0

dicyclohexyl-carbodiimide

Conditions
ConditionsYield
With dichloromethylenedimethyliminium chloride; triethylamine In dichloromethane at 0℃;100%
With bis(trichloromethyl) carbonate In 1-methyl-pyrrolidin-2-one at 30 - 40℃; for 6h; Autoclave;99.5%
With pyridine; chloroacetyl chloride In dichloromethane at 0 - 60℃; for 10h; Solvent; Temperature; Reagent/catalyst;97.3%
1,3-Dicyclohexylurea
2387-23-7

1,3-Dicyclohexylurea

cyclohexylamine
108-91-8

cyclohexylamine

Conditions
ConditionsYield
With sodium hydroxide at 450℃; for 8h; Temperature; Autoclave; Large scale;99.49%
1,3-Dicyclohexylurea
2387-23-7

1,3-Dicyclohexylurea

ethyl N-cyclohexylcarbamate
1541-19-1

ethyl N-cyclohexylcarbamate

Conditions
ConditionsYield
96%
93%
8%
2.6-dimethylphenol
576-26-1

2.6-dimethylphenol

1,3-Dicyclohexylurea
2387-23-7

1,3-Dicyclohexylurea

N-cyclohexyl carbamic acid(2,6-dimethylphenyl)ester
201137-64-6

N-cyclohexyl carbamic acid(2,6-dimethylphenyl)ester

Conditions
ConditionsYield
Reflux; Large scale;95%

2387-23-7Relevant articles and documents

Highly efficient ionic liquid-mediated palladium complex catalyst system for the oxidative carbonylation of amines

Shi, Feng,Peng, Jiajian,Deng, Youquan

, p. 372 - 375 (2003)

A highly efficient catalyst system, palladium-ionic liquid, was developed for the carbonylation of amines to give carbamate or urea. The desired products could be precipitated by adding water into the resulting mixture and the catalyst system could be reused with slight loss of catalytic activity. BMImBF4 ionic liquid + Pd(phen)Cl2 was an effective catalytic system for the oxidative carbonylation of aniline to give corresponding carbamate and for the cyclohexyl amine to give urea. The diversity of the ionic liquids could form an optimal homogeneous catalyst system with a specific organometallic toward specific reactions. There existed strong interactions between the ionic liquid and the Pd complex, which might enhance and stabilize the Pd complex catalyst.

Synthesis, characterization and hirshfeld surface analysis of a 2-thiophene acetic acid derivative

Rani, N. Latha,Chakravarthy,Mohana,Lokanath,Sridhar

, p. 223 - 231 (2015)

N,N′-dicyclohexylcarbamoyl-2-(thiophen-2-yl)acetamide (C19H28N2 O2S), was prepared using 1,3-dicyclohexylurea. The compound has been characterized by IR, and single-crystal X-ray diffraction followed by a detailed Hirshfeld surface analysis. The compound crystallizes in the monoclinic space group P21/c, with cell parameters a = 9.0969(3) ?, b = 18.3067(5) ?, c = 11.6499(3) ?, β = 103.876(2)°, V = 1883.49(10) ?3, Z = 4. The crystal structure of the compound is stabilized by the intermolecular interactions of types N-H?O, C-H?O and intramolecular interactions of the type C-H?O.

Preparation of 5-diaminomethylenebarbiturates by barbituric acid addition to carbodiimides

Jursic, Branko S.,Douelle, Fred,Stevens, Edwin D.

, p. 3427 - 3432 (2003)

Through NMR spectroscopic monitoring of barbituric acid addition to carbodiimide, a general synthetic procedure for the preparation of 5-diaminomethylenebarbiturates (DABA) was developed. This procedure is very simple and applicable to the preparation of large quantities of DABA derivatives. Through an X-ray structural study of one of the DABA derivatives, it was established that these compounds have an ylide-type structure with strong charge separation within the molecule.

Cytotoxicity of doxorubicin conjugated with C60 fullerene. Structural and in vitro studies

Butowska, Kamila,Kozak, Witold,Zdrowowicz, Magdalena,Makurat, Samanta,Rych?owski, Micha?,Ha?, Aleksandra,Herman-Antosiewicz, Anna,Piosik, Jacek,Rak, Janusz

, p. 2327 - 2338 (2019)

Conjugating an anticancer drug of high biological efficacy but large cytotoxicity with a “transporting” molecule of low toxicity constitutes a valuable approach to design safe drug delivery system. In the present study, doxorubicin (DOX) a drug of large cardiotoxicity was chemically conjugated to a C60-fullerene. The synthesized molecule, a fullerene-doxorubicin conjugate (Ful-DOX), was characterized using the 1H NMR and MALDI TOF mass spectrometry. The absorption and fluorescence spectra and dynamic light scattering of the conjugate were recorded in an aqueous solution, while the impact on viability of several cancer cell lines of the free DOX and the conjugate was compared using the SRB and WST-1 assays. A low antiproliferative activity of the conjugate as compared to the free DOX is a consequence of the presence of fullerene moiety in the former, which is also responsible for the conjugate aggregation in an aqueous solution. Unlike free DOX, these aggregates cannot pass through the nuclear membrane (as demonstrated by the confocal microscopy measurements), which makes them marginally cytotoxic.

Molecular interactions of β-cyclodextrins with monolayers containing adamantane and anthraquinone guest groups

Swiech, Olga,Chmurski, Kazimierz,Bilewicz, Renata

, p. 461 - 466 (2010)

Complexing abilities of β-cyclodextrin (β-CD) towards anthraquinone derivatives in solution and immobilised on gold surfaces were studied by voltammetry. The association constant of β-CD with 1-aminoanthraquinone in solution was found to be 1.03±0.05×103 M-1 hence, smaller than that with anthraquinone. Capping the surface-immobilised N-(1-anthraquinone) lipoamide with β-CD led to decrease in the heterogeneous electron transfer rate constant due to the change in the immediate environment around the electroactive group. To detect the interactions of β-CD with a non-electroactive guest, N-(1-adamantane) lipoamide (AD-Lip), the CD was modified by the attachment of an anthraquinone group as the electroactive marker. The appearance of the voltammetric peak corresponding to the reduction of the anthraquinone side-group indicated the binding of β-CD to the AD-Lip self-assembled in a monolayer on the gold electrode.

N-(3-Triethoxysilylpropyl)-4-(isothiocyanatomethyl)-cyclohexane-1-carboxamide (TPICC): A heterobifunctional reagent for immobilization of biomolecules on glass surface

Misra, Arvind,Shahid, Mohammad,Dwivedi, Pratibha

, p. 5217 - 5221 (2008)

An efficient heterobifunctional reagent, N-(3-triethoxysilylpropyl)-4-(isothiocyanatomethyl)cyclohexane-1-carboxamide (TPICC) has been developed by a simple 'two step reaction' for the preparation of bioconjugates and immobilization of biomolecules such as oligonucleotides, peptides and proteins on the glass surface. The isothiocyanate functionality at one end of the reagent, TPICC was found specific for the ligands having either aminoalkyl (RNH2) or mercaptoalkyl (R-SH) functionality. The synthesis of bioconjugates with the reagent was achieved through its isothiocyanate functionality at one end via the formation of stable thiourea linkage with aminoalkyl and dithiocarbamate linkage with mercaptoalkyl derivatives. The triethoxysilyl functionality of the reagent has been utilized for specific coupling with the virgin glass surface by a very simple methodology.

Total Synthesis of (+)-3-Demethoxyerythratidinone and (+)-Erysotramidine via the Oxidative Amidation of a Phenol

Paladino, Marco,Zaifman, Joshua,Ciufolini, Marco A.

, p. 3422 - 3425 (2015)

Oxidative amidation chemistry provides a unified route to aromatic Erythrina alkaloids through a sequence that illustrates new principles and improved conditions to effect a crucial eliminative Curtius-Schmidt rearrangement.

A chirally stable, atropoisomeric, Cα-tetrasubstituted α-amino acid: Incorporation into model peptides and conformational preference

Formaggio, Fernando,Peggion, Cristina,Crisma, Marco,Toniolo, Claudio,Tchertanov, Luba,Guilhem, Jean,Mazaleyrat, Jean-Paul,Goubard, Yolaine,Gaucher, Anne,Wakselman, Michel

, p. 481 - 501 (2001)

A variety of model peptides, including four complete humologous series, to the pentamer level, characterized by the recently proposed binaphthyl-based, axially chiral. Cα-tetrasubstituted, cyclic α-amino acid Bin, in combination with Ala. Gly, or Aib residues, was synthesized by solution methods and fully characterized. The solution conformational propensity of these peptides was determined by FT-IR absorption and 1H-NMR techniques. Moreover, the molecular structures of the free amino acid (S)-enantiomer and an Nα-acylated dipeptide alkylamide with the heterochiral sequence -(R)-Bin-Phe- were assessed in the crystal state by X-ray diffraction. Taken together, the results point to the conclusion that β-bends and 310 helices are preferentially adopted by Bin-containing peprides, although the tully extended conformation would also be adopted in solution by the short oligomers to some extent. We also confirmed the tendency of (R)-Bin to fold a peptide chain into right-handed bend and helical structures. The absolute configuration of the Bin residue(s) was correlated with the typically intense exciton-split Cotton effect of the 1Bb binaphthyl transition near 225 nm.

Biodegradable thermo-sensitive nanoparticles from poly(L-lactic acid)/poly(ethylene glycol) alternating multi-block copolymer for potential anti-cancer drug carrier

Na, Kun,Lee, Kwang Hee,Lee, Don Haeng,Bae, You Han

, p. 115 - 122 (2006)

In order to produce biodegradable thermo-sensitive nanoparticles, alternating multi-block copolymers (MBC) were synthesized by coupling dicarboxylated poly(ethylene glycol) (PEG; Mw 2000) with poly(l-lactic acid) (PLLA)/PEG/PLLA triblock copolymers. Three different multi-block copolymers were synthesized by varying PLLA molecular weight (800 (MBC1), 1600 (MBC2), and 2800 (MBC3)). The MBC formed self-assembled nanoparticles with a unimodal size distribution during a dialysis process. The nanoparticles (NP) had a spherical shape with a size range of 90-330 nm in diameter and critical aggregation concentrations in a range of 5.6-12.6 μg/mL, depending on PLLA length in MBC. The thermo-sensitivity of MBC NP was monitored by the changes in particle size and interior structure as a function of temperature. The particle size slightly decreased as increasing temperature from 37 to 42°C. The interior structure of the NP responded to temperature by altering microviscosity. The microviscosity, measured by the anisotropy (r value) of a fluorescence probe, of MBC1 NP significantly changed with increasing temperature (r = 0.187 at 25°C and 0.216 at 42°C), while MBC2 and MBC3 showed negligible changes in the microviscosity. This indicates that the temperature-dependent interior structure of the NP relied on the portion of PLLA in MBC. The thermo-sensitivity affected to the drug release behavior and cell cytotoxicity. At 42°C, doxorubicin (DOX) loaded MBC1 NP showed enhanced cytotoxicity (~20 times) against Lewis Lung Carcinoma (LLC) cells when compared to that at 37°C.

One-pot synthesis of 4-arylidene imidazolin-5-ones by reaction of amino acid esters with isocyanates and α-bromoketones

Haung, Jia-Yun,Barve, Indrajeet J.,Sun, Chung-Ming

, p. 3040 - 3047 (2019)

A simple and new multicomponent reaction for the one-pot synthesis of substituted 4-arylidene imidazolin-5-ones from l-amino acid methyl esters, iso-, isothio- or isoselenocyanates, and α-bromoketones is demonstrated. Isolation of thiohydantoin and 5-benzylidene 2-thioxoimidazolidin-4-one intermediates revealed a possible reaction mechanism. The strategy was further extended to the synthesis of 2-iminothiazolines and 2-thioxoimidazolin-4-ones.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 2387-23-7